Patents by Inventor Julie C. Lauterborn

Julie C. Lauterborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION
    Publication number: 20130123248
    Abstract: Antagonists of group 1 metabotropic glutamate receptors (mGluR) potentiate the effect of positive AMPA receptor modulators on neurotrophin expression, such as brain-derived neurotrophic factor (BDNF). The findings described herein suggest a combinatorial approach for drug therapies, using both positive AMPA receptor modulators and mGluR antagonists, to enhance brain neurotrophism.
    Type: Application
    Filed: October 17, 2012
    Publication date: May 16, 2013
    Applicant: The Regents of the University of California
    Inventors: Julie C. Lauterborn, Christine M. Gall, Gary Lynch
  • PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION
    Publication number: 20110306601
    Abstract: Antagonists of group 1 metabotropic glutamate receptors (mGluR) potentiate the effect of positive AMPA receptor modulators on neurotrophin expression, such as brain-derived neurotrophic factor (BDNF). The findings described herein suggest a combinatorial approach for drug therapies, using both positive AMPA receptor modulators and mGluR antagonists, to enhance brain neurotrophism.
    Type: Application
    Filed: August 19, 2011
    Publication date: December 15, 2011
    Applicant: The Regents of the University of California
    Inventors: Julie C. Lauterborn, Christine M. Gall, Gary Lynch
  • PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION
    Publication number: 20090192199
    Abstract: Antagonists of group 1 metabotropic glutamate receptors (mGluR) potentiate the effect of positive AMPA receptor modulators on neurotrophin expression, such as brain-derived neurotrophic factor (BDNF). The findings described herein suggest a combinatorial approach for drug therapies, using both positive AMPA receptor modulators and mGluR antagonists. to enhance brain neurotrophism.
    Type: Application
    Filed: April 19, 2007
    Publication date: July 30, 2009
    Applicant: The Regents of the University of California
    Inventors: Julie C. Lauterborn, Christine M. Gall, Gary Lynch
  • Positive AMPA receptor modulation to enhance brain neurotrophic factor expression
    Patent number: 6030968
    Abstract: Methods for increasing the level of neurotrophic factors and neurotrophic factor receptors in the brain of a mammal afflicted with a pathology which produces neurodegeneration without significant loss of memory or learning comprising administering to a mammal an effective amount of an allosteric upmodulator of .alpha.-amino-3-hydroxy-5-methyl-isoxazole-4-proprionic acid (AMPA) receptors.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: February 29, 2000
    Assignee: The Regents of the University of California
    Inventors: Christine M. Gall, Gary S. Lynch, Julie C. Lauterborn, Peter W. Vanderklish